Business Context and Reporting Period
This Form 8-K Current Report was filed by SeaStar Medical Holding Corp (Nasdaq: ICU) on September 23, 2025. The company is an emerging growth company incorporated in Delaware with principal executive offices in Denver, Colorado. The report details corporate governance actions regarding executive and director compensation effective October 1, 2025.
Key Financial Metrics
The filing does not provide specific values for revenue, profit, cash flow, margins, debt, or liquidity. The only quantified financial impact disclosed is an expected increase in monthly operating expenses of approximately $50,000 resulting from the compensation adjustments.
Material Changes Versus Prior Period
The Board of Directors reversed a cost-cutting measure implemented in June 2025. Previously, the annual base salaries of the CEO (Eric Schlorff) and CMO (Kevin Chung), along with other management, were reduced by 20%. Similarly, directors' cash retainer fees were reduced by 20%. The current filing announces the restoration of these salaries and retainers to their original 2024 levels.
Guidance, Outlook, and Management Commentary
Management commentary indicates a strategic shift from the expense reduction efforts of June 2025. The Board approved the salary and retainer increases to restore compensation to pre-reduction levels. The company explicitly states that these actions will result in an approximate $50,000 increase in monthly operating expenses. No forward-looking guidance regarding revenue or profitability is provided in this filing.
Important Facts for Investor Verification
- Effective October 1, 2025, executive salaries and director retainers are restored to 2024 levels after a 20% reduction in June 2025.
- Monthly operating expenses are projected to rise by approximately $50,000 due to these compensation changes.
- The filing contains no data on the company's current cash position, revenue, or debt levels.
- Investors should verify the company's total cash runway given the increase in fixed operating costs.